Tedeschi A, Frustaci AM, Menna P, Minotti G, et al. Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib. Leukemia 2025 Oct 2. doi: 10.1038/s41375-025-02778.
PMID: 41038988